Literature DB >> 30079976

Identification of α-Mangostin as an Agonist of Human STING.

Yibo Zhang1, Zhen Sun2, Jianwen Pei1, Qinhong Luo1, Xin Zeng1, Qinkai Li1, Zhen Yang1,2, Junmin Quan1.   

Abstract

The xanthone derivate 5',6'-dimethylxanthenone-4-acetic acid (DMXAA, also known as ASA404 or vadimezan) is a potent agonist of murine STING (stimulator of interferon genes), but cannot activate human STING. Herein we report that α-mangostin, which bears the xanthone skeleton, is an agonist of human STING, but activates murine STING to a lesser extent. Biochemical and cell-based assays indicate that α-mangostin binds to and activates human STING, leading to activation of the downstream interferon regulatory factor (IRF) pathway and production of type I interferons. Furthermore, our studies show that α-mangostin has the potential to repolarize human monocyte-derived M2 macrophages to the M1 phenotype. The agonist effect of α-mangostin in the STING pathway might account for its antitumor and antiviral activities.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  STING; macrophage repolarization; tumor microenvironment; type I interferon; α-mangostin

Mesh:

Substances:

Year:  2018        PMID: 30079976     DOI: 10.1002/cmdc.201800481

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  18 in total

Review 1.  Interrupting cyclic dinucleotide-cGAS-STING axis with small molecules.

Authors:  Herman O Sintim; Clinton G Mikek; Modi Wang; Moloud A Sooreshjani
Journal:  Medchemcomm       Date:  2019-08-15       Impact factor: 3.597

2.  Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist.

Authors:  Xiaohui Zhang; Bowei Liu; Liudi Tang; Qing Su; Nicky Hwang; Mohit Sehgal; Junjun Cheng; Julia Ma; Xuexiang Zhang; Yinfei Tan; Yan Zhou; Zhongping Duan; Victor R DeFilippis; Usha Viswanathan; John Kulp; Yanming Du; Ju-Tao Guo; Jinhong Chang
Journal:  ACS Infect Dis       Date:  2019-05-14       Impact factor: 5.084

Review 3.  Advances in plant-derived natural products for antitumor immunotherapy.

Authors:  Yi Yang; Qinying Liu; Xianai Shi; Qiuhong Zheng; Li Chen; Yang Sun
Journal:  Arch Pharm Res       Date:  2021-11-09       Impact factor: 4.946

4.  WDR74 facilitates TGF-β/Smad pathway activation to promote M2 macrophage polarization and diabetic foot ulcer wound healing in mice.

Authors:  Kang Geng; Xiumei Ma; Zongzhe Jiang; Junling Gu; Wei Huang; Weiming Wang; Yong Xu; Youhua Xu
Journal:  Cell Biol Toxicol       Date:  2022-08-19       Impact factor: 6.819

5.  Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues.

Authors:  Yuta Yanase; Genichiro Tsuji; Miki Nakamura; Norihito Shibata; Yosuke Demizu
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

Review 6.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

Review 7.  Nanodelivery of STING agonists against cancer and infectious diseases.

Authors:  Jiarong Zhou; Christian J Ventura; Ronnie H Fang; Liangfang Zhang
Journal:  Mol Aspects Med       Date:  2021-08-02

Review 8.  STING and transplantation: can targeting this pathway improve outcomes?

Authors:  Cameron S Bader; Lei Jin; Robert B Levy
Journal:  Blood       Date:  2021-04-08       Impact factor: 22.113

9.  In Vitro Antiviral Activity of α-Mangostin against Dengue Virus Serotype-2 (DENV-2).

Authors:  Kingshuk Panda; Kalichamy Alagarasu; Poonam Patil; Megha Agrawal; Ashwini More; Naveen V Kumar; Prathama S Mainkar; Deepti Parashar; Sarah Cherian
Journal:  Molecules       Date:  2021-05-19       Impact factor: 4.411

Review 10.  Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.

Authors:  Juyan Zheng; Junluan Mo; Tao Zhu; Wei Zhuo; Yueneng Yi; Shuo Hu; Jiye Yin; Wei Zhang; Honghao Zhou; Zhaoqian Liu
Journal:  Mol Cancer       Date:  2020-08-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.